...
首页> 外文期刊>Materials science & engineering >In vitro and in vivo evaluation of bioglass microspheres incorporated brushite cement for bone regeneration
【24h】

In vitro and in vivo evaluation of bioglass microspheres incorporated brushite cement for bone regeneration

机译:体外和体内评价生物胶质微球,含有骨再生的黑晶水泥

获取原文
获取原文并翻译 | 示例

摘要

Bioglass-calcium phosphate cement (CPC) composite materials have recently received increased attention for bone regeneration purposes, owing to their improved properties in term of biocompatibility and bone ingrowths. In this study, an injectable bone substitute (IBS) system which utilizes bioglass microspheres incorporated into brushite based cement, was evaluated. The microspheres were synthesized with a simple and low sintering temperature process; there was no significant phase difference shown from the powder and good interactivity with cells was obtained. Furthermore, physical properties were optimized in microsphere incorporated brushite cement in order to investigate in vitro and in vivo performance. Accordingly, setting time and compressive strength were hardly altered until a microsphere content of 40% (v/v) was reached. The brushite (BR)/bioglass microsphere (BM) system showed excellent bioactivity to the in-vitro simulated body fluid test: dissolution ions from composite materials influenced apatite growth, countered acidic pH, and increased material degradation. In an in-vitro study with preosteoblasts (MC3T3-E1), BR/BM supported cell adhesion and proliferation, while cell differentiation experiments without osteogenic supplements, demonstrated that BR/BM induced osteogenic differentiation. A post-implantation study conducted in femoral defects showed higher materials degradation and bone formation in BR/BM than in BR. The faster dissolution of bioglass microspheres increased BR/BM composite resorption and hence facilitated bone tissue integration. Our findings suggest that bioglass microspheres incorporated in cement could potentially be used as an injectable bone substitute for bone regeneration applications.
机译:磷酸盐钙水泥(CPC)复合材料最近接受了骨再生目的的增加,由于其在生物相容性和骨骼的术语中的性质改善。在该研究中,评价了利用掺入黑晶体基水泥的生物加工微球的可注射骨替代(IBS)系统。用简单且低烧结温度工艺合成微球;没有从粉末中显示显着的相差,并获得与细胞的良好相互作用。此外,在微球中优化了物理性质,以便在体外和体内性能中进行研究。因此,在达到40%(v / v)的微球含量直至达到40%(v / v)的凝固时间和抗压强度。石油石(BR)/生物加工微球(BM)系统显示出优异的生物活性与体外模拟体液试验:来自复合材料的溶出离子影响磷灰石生长,反酸性pH和提高的物质降解。在具有预卵细胞(MC3T3-E1)的体外研究中,BR / BM负载的细胞粘附和增殖,而没有成骨补充剂的细胞分化实验,证明了BR / BM诱导的骨质发生分化。在股骨缺陷中进行的植入后研究表明,BR / BM的较高的材料降解和骨形成而不是BR。生物胶质微球的溶解率较快增加BR / BM复合体积,因此有助于骨组织集成。我们的研究结果表明,在水泥中掺入的生物胶质微球可能被用作骨再生应用的可注射骨骼。

著录项

  • 来源
    《Materials science & engineering 》 |2019年第10期| 109775.1-109775.12| 共12页
  • 作者单位

    Soonchunhyang Univ Coll Med Dept Regenerat Med 366-1 Ssangyong Dong Cheonan 330090 Chungcheongnam South Korea;

    Soonchunhyang Univ Coll Med Inst Tissue Regenerat 366-1 Ssangyong Dong Cheonan 330090 Chungcheongnam South Korea;

    Soonchunhyang Univ Coll Med Inst Tissue Regenerat 366-1 Ssangyong Dong Cheonan 330090 Chungcheongnam South Korea;

    Soonchunhyang Univ Coll Med Dept Regenerat Med 366-1 Ssangyong Dong Cheonan 330090 Chungcheongnam South Korea;

    Soonchunhyang Univ Coll Med Dept Regenerat Med 366-1 Ssangyong Dong Cheonan 330090 Chungcheongnam South Korea;

    Soonchunhyang Univ Coll Med Dept Regenerat Med 366-1 Ssangyong Dong Cheonan 330090 Chungcheongnam South Korea|Soonchunhyang Univ Coll Med Inst Tissue Regenerat 366-1 Ssangyong Dong Cheonan 330090 Chungcheongnam South Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Injectable bone substitute; Bioglass microspheres; Brushite; Biocompatibility;

    机译:可注射骨替代;生物胶质微球;血管石;生物相容性;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号